STOCK TITAN

Certara to Participate in Upcoming Investor Conferences

Certara, a leader in biosimulation, announced participation in upcoming virtual investor conferences.

(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Tags
conferences

Rhea-AI Summary

Certara, a leader in biosimulation, announced participation in upcoming virtual investor conferences. Key events include the Morgan Stanley Global Healthcare Conference on September 14 at 9:30 a.m. ET, featuring CEO William Feehery and CFO Andrew Schemick; the Baird Global Healthcare Conference on September 15 at 4:55 p.m. ET, with CFO Andrew Schemick; and the Bank of America Securities Drug Discovery Conference on September 20 at 8:00 a.m. ET, with both executives. Live webcasts will be available on Certara’s investor relations website for 90 days.

Loading...
Loading translation...
Argus Session date unavailable
+1.22% session move Open Argus
Details

News Market Reaction – CERT

The recorded move for CERT in the trading session of this news was +1.22%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

PRINCETON, N.J., Aug. 31, 2021 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that Company management will participate in a fireside chat at the following virtual investor conferences:

  • Morgan Stanley 19th Annual Global Healthcare Conference
    Date and Time: Tuesday, September 14 at 9:30 a.m. ET
    Speakers: William Feehery, chief executive officer, and Andrew Schemick, chief financial officer
  • Baird 2021 Global Healthcare Conference
    Date and Time: Wednesday, September 15 at 4:55 p.m. ET
    Speaker: Andrew Schemick, chief financial officer
  • Bank of America Securities 2021 Tech Solutions for Drug Discovery Conference
    Date and Time: Monday, September 20 at 8:00 a.m. ET
    Speakers: William Feehery, chief executive officer, and Andrew Schemick, chief financial officer

Live webcasts for each of the conferences will be available on Certara’s investor relations website at https://ir.certara.com and will be available for replay for at least 90 days thereafter.

About Certara
Certara accelerates medicines using biosimulation software and technology to transform traditional drug discovery and development. Its clients include more than 1,650 global biopharmaceutical companies, leading academic institutions, and key regulatory agencies across 61 countries.

Investor Relations Contact:
David Deuchler
Gilmartin Group
ir@certara.com

Media Contact:
Ariane Lovell
Finn Partners
ariane.lovell@finnpartners.com 


FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What are the upcoming investor conferences for Certara in September 2021?

Certara will participate in three conferences: Morgan Stanley Global Healthcare Conference on September 14, Baird Global Healthcare Conference on September 15, and Bank of America Securities Drug Discovery Conference on September 20.

Who will represent Certara at the Morgan Stanley Global Healthcare Conference?

William Feehery, the CEO, and Andrew Schemick, the CFO, will represent Certara at the Morgan Stanley Global Healthcare Conference.

What time is Certara's participation in the Baird Global Healthcare Conference?

Certara will present at the Baird Global Healthcare Conference on September 15 at 4:55 p.m. ET.

Where can I watch Certara's investor conference webcasts?

The live webcasts for Certara's investor conferences can be viewed on their investor relations website, with replay available for at least 90 days.

What is the focus of Certara's business?

Certara specializes in accelerating medicine development using biosimulation software, working with over 1,650 biopharmaceutical companies, academic institutions, and regulatory agencies globally.

Keep reading